Biopharma quality control is being revolutionized by advanced analytics and digital transformation through a synergy that ...
In this PharmTech video feature, we highlight the week’s industry news in an easy-to-consume, fun format. New roundups will ...
Large-language models are excellent for general-use AI systems, but they don’t understand pharmaceutical companies’ ...
Facility design should integrate risk mitigation strategies, focusing on contamination prevention and reliable utility ...
“Etheros represents an investment in a differentiated platform addressing oxidative stress through catalytic antioxidants,” Boyang Wang, founder of Immortal Dragons, said in the press release (1).
FDA has granted orphan drug designation to FS2 (kynurenic acid) for the investigational treatment of idiopathic pulmonary ...
Several European biotechs, including Cellbox Labs, Evotec SE, Nanolive SA, and Salipro Biotech AB, have developed innovative ...
FDA announced on Dec. 1, 2025 that it will be providing agency staff with agentic artificial intelligence (AI) capabilities ...
Several 3D printing technologies are currently considered more clinically applicable, including SSE, fused deposition ...
Advanced technologies in pharma manufacturing necessitate a redefinition of the Qualified Person's role, focusing on digital ...
Gain leadership and innovation insights from CEO of the Year finalist at 2025 CPHI Pharma Awards, Mahler Hanns-Christian, who ...
The CNPV pilot program significantly reduces review times, but may challenge safety standards and resource allocation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results